Correct quantities for PharmaCare claims
Last updated on May 6, 2025This is a summary of Correct Quantities Policy — Section 5.5, PharmaCare Policy Manual.
Use the units of measure below when entering claims in PharmaNet. Use CTRL+F or the search box to search by item or DIN.
PharmaCare is winding down payments to pharmacies for distribution of RAT kits. The last day to order RAT kits that are eligible for the PharmaCare distribution fee is May 31, 2025. Pharmacies have until June 30, 2025 to submit claims for the distribution fee. For more details, refer to the May 2025 PharmaCare Newsletter.
If you don't know which unit of measure to use, are having trouble entering a decimal, or want to suggest an addition to these lists, please email pharma@gov.bc.ca.
On this page: General categories | Specific items | Inhaled medications
General categories
- Creams or ointments: weight in grams
-
- Liquid, injectable: volume in millilitres or number of vials
- Nebulizers and other inhaled medications: volume in millilitres (see also list of specific inhaled medications)
- Patches: number of patches
- Powders for injection: grams or number of vials
- Prefilled vaccine syringes: volume in millilitres (e.g., 0.5 mL)
- Pre-loaded syringes: number of syringes
- Sprays: number of doses (if provided on packaging); otherwise, volume in millilitres
- Suppositories: number of suppositories
- Tablet/capsules/caplets: number of tablets or capsules or caplets
Specific items
| Medication | DIN | Unit of measure | |||
|---|---|---|---|---|---|
| abatacept (Orencia®) | 02282097 | Number of vials | |||
| adalimumab (Abrilada™) 20 mg/0.4 mL | 02511061 | Number of syringes | |||
| adalimumab (Abrilada™) 40 mg/0.8 mL | 02511053 02511045 |
Number of syringes Number of pens |
|||
| adalimumab (Amgevita®) 20 mg/0.4 mL | 02459310 | Number of syringes | |||
| adalimumab (Amgevita®) 40 mg/0.8 mL | 02459299 02459302 |
Number of syringes Number of autoinjectors |
|||
| adalimumab (Hadlima®) 40 mg/0.8 mL | 02473097 02473100 |
Number of syringes Number of autoinjectors |
|||
adalimumab (Hadlima® and Hadlima PushTouch®) 40 mg/0.4 mL
|
02533472 02533480 |
Number of syringes Number of autoinjectors |
|||
| adalimumab (Hulio®) 20 mg/0.4 mL | 02502380 | Number of syringes | |||
| adalimumab (Hulio®) 40 mg/0.8 mL | 02502399 02502402 |
Number of syringes Number of pens |
|||
| adalimumab (Humira®) | 02258595 | Number of syringes | |||
| adalimumab (Hyrimoz®) 20 mg/0.4 mL | 02505258 | Number of syringes | |||
| adalimumab (Hyrimoz®) 40 mg/0.8 mL | 02492156 02492164 |
Number of autoinjectors Number of syringes |
|||
| adalimumab (Hyrimoz®) 20 mg/0.2 mL | 02542315 | Number of syringes | |||
| adalimumab (Hyrimoz®) 40 mg/0.4 mL | 02542323 02542331 |
Number of syringes Number of autoinjectors |
|||
| adalimumab (Hyrimoz®) 80 mg/0.8 mL | 02542358 02542366 |
Number of syringes Number of autoinjectors |
|||
| adalimumab (Idacio®) 40 mg/0.8 mL | 02502674 | Number of pens | |||
| adalimumab (Idacio®) 40 mg/0.8 mL | 02502682 | Number of prefilled syringes | |||
| adalimumab (Simlandi™) 40 mg/0.4 mL | 02523949 02523957 |
Number of syringes Number of autoinjectors |
|||
| adalimumab (Simlandi™) 80 mg/0.8 mL | 02523965 | Number of syringes | |||
| adalimumab (Yuflyma®) 40 mg/0.4 mL | 02523779 02523760 |
Number of pens Number of syringes |
|||
adalimumab (Yuflyma®) 80 mg/0.8 mL
|
02535076 02535084 |
Number of syringes Number of pre-filled pens |
|||
| alemtuzumab (Lemtrada®) | 02418320 | Volume in millilitres | |||
| baclofen (Lioresal® intrathecal 0.5 mg/mL) | 02131056 | Volume in millilitres | |||
| baclofen (VPI-Baclofen® Intrathecal 0.5 mg/mL) | 02413639 | Number of ampoules (1 ampoule = 20 mL) | |||
| bimekizumab (Bimzelx®) 160 mg/mL | 02525275 02525267 |
Number of autoinjectors Number of syringes |
|||
| botulinum neurotoxin A, with complexing proteins, also known as onabotulinumtoxinA (Botox®) |
01981501 |
Number of units | |||
| botulinum neurotoxin A, free from complexing proteins, also known as incobotulinumtoxinA (Xeomin®) | 02324032 02371081 |
Number of vials | |||
| budesonide foam (Uceris®) 2 mg per actuation | 02498057 | Number of actuations | |||
| buprenorphine extended-release injection (Sublocade™) | 02483084 02483092 09858127 09858128 |
Number of syringes | |||
| butorphanol (Stadol®) | 02113031 | Number of doses (14 per bottle) | |||
| calcitonin (Calcimar) | 01926691 | Number of vials | |||
| certolizumab (Cimzia™) | 02331675 | Number of syringes | |||
| colistimethate sodium | 02244849 | Number of vials | |||
| colistimethate sodium (Coly‑Mycin M Parenteral®) | 00476420 | Number of vials | |||
| continuous glucose monitor (Dexcom®) | see drug list | Pieces within a kit (e.g. 1 kit containing 3 sensors and 1 transmitter = 4) | |||
| Creon® Minimicrospheres™ | 02445158 | Number of scoops (of 100 mg) | |||
| cystic fibrosis supplies: liquids | see drug list | Volume in millilitres | |||
| cystic fibrosis supplies: tablets | see drug list | Number of tablets | |||
| cystic fibrosis supplies: capsules | see drug list | Number of capsules | |||
| cystic fibrosis supplies: caplets | see drug list | Number of caplets | |||
| dalteparin (Fragmin®) | 02132664 02231171 02132621 02132648 02352648 02352672 02352656 02352664 02352680 02494582 |
Volume in millilitres | |||
| denosumab (XGEVA®) | 02368153 | Volume in millilitres | |||
| denosumab (Wyost™) | 02545764 | Volume in millilitres | |||
| desmopressin acetate nasal spray | 02242465 | Volume in millilitres (25 doses = 2.5 mL; 50 doses = 5 mL) | |||
| dorzolamide with preservative (Trusopt®) | 02216205 | Volume in millilitres | |||
| dorzolamide with preservative (Apo-dorzolamide) | 02296055 | Volume in millilitres | |||
| dorzolamide preservative-free (Trusopt®) | 02269090 | Number of units (1 unit = 0.2 mL) | |||
| dupilumab (Dupixent®) | 02492504 | Volume in millilitres | |||
| dupilumab (Dupixent®) | 02470365 | Volume in millilitres | |||
| dupilumab (Dupixent®) | 02510049 | Volume in millilitres | |||
| dupilumab (Dupixent®) | 02524252 | Volume in millilitres | |||
| edaravone (Radicava™) | 02475472 | Volume in millilitres | |||
| enoxaparin (Inclunox®) | 02507501 02507528 02507536 02507544 02507552 |
Volume in millilitres | |||
| enoxaparin (Inclunox® HP) | 02507560 02507579 |
Volume in millilitres | |||
| enoxaparin (Noromby®) | 02506440 02506459 02506467 02506475 02506483 02506491 |
Volume in millilitres | |||
| enoxaparin (Noromby® HP) | 02506505 02506513 |
Volume in millilitres | |||
| enoxaparin (Redesca®) | 02509075 02509083 02509091 02509105 02509113 02509121 |
Volume in millilitres | |||
| enoxaparin (Redesca® HP) | 02509148 02509156 |
Volume in millilitres | |||
| enoxaparin (Elonox®) | 02532247 02532255 02532263 02532271 02532298 |
Volume in millilitres | |||
| enoxaparin (Elonox® HP) | 02532301 02532328 |
Volume in millilitres | |||
| eptinezumab (Vyepti®) | 02510839 02542269 |
Number of vials | |||
|
etanercept 50 mg (Brenzys®)
|
2455331 2455323 |
Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen = 7-day supply |
|||
| etanercept 50 mg (Enbrel®) pre-filled syringe | 02274728 | Number of syringes (each 50 mg syringe is 1 mL) Usual dosing is 1 syringe = 7-day supply |
|||
| etanercept 25 mg (Erelzi®) pre-filled syringe | 02462877 | Number of syringes (each 25 mg syringe is 0.5 mL) Usual dosing is 1 syringe = 7-day supply |
|||
etanercept 50 mg (Erelzi®)
|
02462850 02462869 |
Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen = 7-day supply |
|||
etanercept (Rymti®)
|
02530295 02530309 |
Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen – 7-day supply |
|||
| evolocumab (Repatha™) | 02459779 | Number of syringes (420 mg/3.5 mL pre-filled cartridge) | |||
| filgrastim (Grastofil®) | 02441489 02454548 |
Price per syringe | |||
| Filgrastim (Nivestym®) | 02485575 02485583 02485591 02485656 |
Price per syringe Price per syringe Price per vial Price per vial |
|||
| Filgrastim (Nypozi™) | 02520990 02521008 |
Price per syringe | |||
| flash glucose monitor (FreeStyle Libre 2®) | see drug list | Number of kits (1 kit contains 1 sensor) | |||
| foslevodopa/foscarbidopa (Vyalev™) | 02537702 | Volume in millilitres | |||
| fremanezumab (Ajovy®) 225 mg/1.5 mL | 02497859 | Number of syringes | |||
| fremanezumab (Ajovy®) 225 mg/1.5 mL | 02509474 | Number of autoinjectors | |||
| galcanezumab (Emgality®) 120 mg/1 mL | 02491060 02491087 |
Number of syringes Number of pre-filled pens |
|||
| glatiramer (Copaxone®) | 02233014 | Number of kits | |||
| glatiramer (Copaxone®) | 02245619 | Number of kits (1 kit contains 30 – 1 mL syringes) | |||
| glucagon nasal powder (Baqsimi®) | 02492415 | Number of devices | |||
| golimumab (Simponi®) | 02324784 02324776 |
Volume in millilitres | |||
| glycerol phenylbutyrate (Ravicti®) | 02453304 | Volume in millilitres | |||
| icatibant (Firazyr®) | 02425696 | Volume in millilitres | |||
| infliximab (Inflectra®) | 02419475 | Number of vials | |||
| infliximab (Ixifi®) | 02523191 | Number of vials | |||
| infliximab (Remdantry™) | 02419475 | Number of vials | |||
| infliximab (Remicade®) | 02244016 | Number of vials | |||
| infliximab (Renflexis®) | 02470373 | Number of vials | |||
| Infliximab (Remsima™) | 02511576 02511584 |
Number of syringes Number of pens |
|||
| inhalers and inhalants: see table below | |||||
| insulin | see drug list | Total volume in millilitres | |||
| insulin pump supplies | see drug list | Total pieces within kit(s) dispensed, e.g., 1 kit containing 1 cannula and 1 tubing = 2; for1 kit containing 10 cannula and 10 tubing = 20; for 2 kits each containing 10 cannula and 10 tubing = 40; for 1 box of pods containing 10 pods = 10 | |||
| interferon alfa-2b (Intron A®) | 02223406 02231651 |
Number of vials | |||
| interferon beta (Avonex®) interferon beta (Avonex-PS®) |
02237770 02269201 |
Number of kits | |||
| interferon beta-1a (Rebif®) | 02281708 02237317 02237319 02237320 |
Number of syringes | |||
| interferon beta-1a (Rebif®) | 02318253 02318261 |
Number of cartridges | |||
| interferon beta-1b (Betaseron®) | 02169649 | Number of vials | |||
| interferon beta-1b (Extavia®) | 02337819 | Number of vials | |||
| mepolizumab (Nucala®) | 02449781 | Number of vials | |||
| mepolizumab (Nucala®) | 02492989 | Number of autoinjector | |||
| mepolizumab (Nucala®) | 02492997 | Number of syringes | |||
| mifepristone - misoprostol (Mifegymiso®) | 02444038 | Number of boxes containing one full course of medication | |||
| mirikizumab (Omvoh™) |
02539861 |
Volume in millilitres | |||
| nadroparin calcium (Fraxiparine®) | 02236913 02450623 02450631 02450658 02450615 |
Volume in millilitres | |||
| nadroparin calcium (Fraxiparine® Forte) |
02450674 02450666 02240114 |
Volume in millilitres | |||
| natalizumab (Tysabri®) | 02286386 | Volume in millilitres | |||
| nirmatrelvir/ritonavir (Paxlovid™) | 02524031 02527804 |
Package (package has 30 tablets) Package (package has 20 tablets) |
|||
| peginterferon alfa-2a (Pegasys®) | 02248077 02248078 |
Volume in millilitres | |||
| sodium phenylbutyrate (Pheburane®) | 02436663 | Weight in grams | |||
| pirfenidone (Esbriet®) | 02393751 | Number of capsules | |||
| pirfenidone (Esbriet®) | 02464489 02464500 | Number of tablets | |||
| pneumococcal vaccine polyvalent (Pneumovax®) | 00431648 | Number of vials (10 x 0.5 mL vials per box) | |||
| rectal enema preparations | see drug list | Volume in millilitres (e.g., 1 box = 7 x 100 mL = 700 mL) | |||
| risankizumab (Skyrizi®) | 02487545 02519283 02519291 02532107 02532093 |
Number of syringes Number of syringes Number of pens Number of vials Number of cartridges |
|||
| risperidone (Risperdal® Consta™) | 02255707 02255723 02255758 |
Number of vials | |||
| romosozumab (Evenity®) 105 mg/1.17 mL pre-filled syringe | 02489597 | Volume in in mililiters (1 syringe = 1.2 mL) | |||
| sarilumab (Kevzara®) | 02460521 02472961 02460548 02472988 |
Number of prefilled syringes or prefilled pens (each syringe or pen is 1.14 mL) Usual dosing is one syringe or pen = 14-day supply |
|||
| semaglutide (Ozempic®) 1.34 mg/mL | 02471477 | Volume in milliliters (one pre-filled pen = 1.5 mL) | |||
| semaglutide (Ozempic®) 1.34 mg/mL | 02471469 | Volume in milliliters (one pre-filled pen = 3 mL) | |||
| semaglutide (Ozempic®) 0.68 mg/mL | 02540258 | Volume in milliliters (one pre-filled pen = 3 mL) | |||
| sumatriptan (Imitrex®) | 02361698 | Volume in millilitres | |||
tezepelumab (Tezspire™) 210 mg/1.91 mL
|
02529548 02529556 |
Volume in mililiters (1 syringe= 1.9mL) | |||
| thiamine HCL inj USP 100 mg/mL | see drug list | Volume in millilitres | |||
| tinzaparin (Innohep®) | 02429462 02429470 02429489 02167840 02229515 02229755 02231478 02358158 02358166 02358174 02358182 |
Volume in millilitres | |||
| tobramycin injection USP | 00533688 | Number of vials | |||
| tobramycin for injection USP | 02230640 02241209 02241210 |
Volume in millilitres | |||
| tocilizumab (Actemra®) syringe | 02424770 | Number of prefilled syringes | |||
| tocilizumab (Actemra) autoinjector | 02483327 | Number of autoinjectors | |||
| ustekinumab (Stelara®) | 02320673 02320681 |
Number of vials or prefilled syringes | |||
| ustekinumab (Jamteki™) | 02543036 02543044 |
Number of prefilled syringes | |||
|
ustekinumab (Steqeyma®) 45 mg/0.5 mL prefilled syringe |
02550245 | Number of prefilled syringes | |||
|
ustekinumab (Steqeyma®) 90 mg/1 mL prefilled syringe |
02550253 | Number of prefilled syringes | |||
|
ustekinumab (Steqeyma®) 130 mg/26 mL intravenous infusion |
02550261 | Volume in millilitres | |||
|
ustekinumab (Wezlana™) 45 mg/0.5 mL prefilled syringe |
02544180 | Number of prefilled syringes | |||
|
ustekinumab (Wezlana™) 90 mg/1 mL prefilled syringe |
02544199 | Number of prefilled syringes | |||
|
ustekinumab (Wezlana™) single-use vial |
02544202 | Number of vials | |||
|
ustekinumab (Wezlana™) intravenous infusion |
02544210 | Volume in millilitres | |||
| vancomycin | 02241821 02139383 |
Number of (1-gram) vials | |||
| zoledronic acid (Aclasta®) | 02269198 | Volume in millilitres | |||
Inhaled medications
| Medication | DIN/PIN | Pack size | Unit of measure |
|---|---|---|---|
| Advair® inhalation aerosol 125 | 02245126 | 120 doses per canister | Number of doses |
| Advair® inhalation aerosol 250 | 02245127 | 120 doses per canister | Number of doses |
| Advair® 250 diskus | 02240836 | 28 or 60 blisters (doses) | Number of doses |
| Advair® 500 diskus | 02240837 | 28 or 60 blisters (doses) | Number of doses |
| Aermony® RespiClick™ 55 mcg/actuation | 02467895 | 60 doses per inhaler | Number of doses |
| Aermony® RespiClick 113 mcg/actuation | 02467909 | 60 doses per inhaler | Number of doses |
| Aermony® RespiClick 232 mcg/actuation | 02467917 | 60 doses per inhaler | Number of doses |
| Atrovent® HFA inhalation aerosol | 02247686 | 200 doses per canister | Number of doses |
| Asmanex® Twisthaler™ | 02243595 | 60 doses per inhaler | Number of doses |
| Asmanex® Twisthaler™ | 02243596 | 30 and 60 doses per inhaler | Number of doses |
| Breztri® Aerosphere™ 182/8.2/5.8 mcg/dose | 02518058 | 120 doses per inhaler | Number of doses |
| Combivent® inhalation aerosol | 02163721 | 100 and 200 dose canisters | Number of doses |
| dornase alfa (Pulmozyme®) | 02046733 | 30 (1 mg/mL) 2.5 mL ampoules | Volume in millilitres |
| Flovent® HFA 125 | 02244292 | 60 and 120 dose canisters | Number of doses |
| Flovent® HFA 250 | 02244293 | 60 and 120 dose canisters | Number of doses |
| Incruse® Ellipta™ 62.5 mcg/dose | 02423596 | 30 doses per inhaler | Number of doses |
| Pulmicort® nebuamp 0.5 mg/mL | 01978926 | 20 (40 mL) and 30 (60 mL) ampoules | Volume in millilitres |
| Pulmicort® turbuhaler 200 mcg/dose | 00851752 | 200 doses per inhaler | Number of doses |
| Pulmicort® turbuhaler 400 mcg/dose | 00851760 | 200 doses per inhaler | Number of doses |
|
rapid antigen test (RAT) kit case (Biontix®) Only kits ordered by May 31, 2025 are eligible for the PharmaCare distribution fee. Learn more |
66128325 | Multiple kits per case, multiple tests per kit | Number of cases |
|
rapid antigen test (RAT) kit case (Artron®) Only kits ordered by May 31, 2025 are eligible for the PharmaCare distribution fee. Learn more |
66128338 | Multiple kits per case, multiple tests per kit | Number of cases |
| ratio-salbutamol HFA | 02244914 | 200 doses per canister | Number of doses |
| Spiriva® Respimat™ 2.5 mcg/dose | 02435381 | 60 doses per canister | Number of doses |
| Symbicort® 200 turbuhaler | 02245386 | 60 or 120 doses per inhaler | Number of doses |
| Trelegy® Ellipta™ 100/62.5/25 mcg/dose | 02474522 | 30 doses per inhaler | Number of doses |
| Zenhale® inhalation aerosol 50/5 | 02361744 | 120 doses per canister | Number of doses |
| Zenhale® inhalation aerosol 100/5 | 02361752 | 120 doses per canister | Number of doses |
| Zenhale® inhalation aerosol 200/5 | 02361760 | 120 doses per canister | Number of doses |